Literature DB >> 11238865

Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival.

W E Hobbs1, D E Brough, I Kovesdi, N A DeLuca.   

Abstract

Herpes simplex virus (HSV) ICP0 can effectively activate gene expression from otherwise silent promoters contained on persisting viral genomes. However, the expression of high levels of ICP0, as from ICP4(-) HSV type 1 (HSV-1) vectors, results in marked toxicity. We have analyzed the results of ICP0 expressed from an E1(-) E4(-) adenovirus vector (AdS.11E4ICP0) in which ICP0 expression is controlled from the endogenous adenoviral E4 promoter. In this system, the expression level of ICP0 was reduced more than 1,000-fold relative to the level of expression from HSV-1 vectors. This low level of ICP0 did not affect cellular division or greatly perturb cellular metabolism as assessed by gene expression array analysis comparing the effects of HSV and adenovirus vector strains. However, this amount of ICP0 was sufficient to quantitatively destroy ND10 structures as measured by promyelocytic leukemia immunofluorescence. The levels of adenovirus-expressed ICP0 were sufficient to activate quiescent viral genomes in trans and promote persistent transgene expression in cis. Moreover, infection of complementing cells with AdS.11E4ICP0 promoted viral growth and resulted in a 20-fold increase in the plaquing efficiency of d109, a virus defective for all five immediate-early genes. Thus, the low level expression of ICP0 from the E1(-) E4(-) adenovirus vector may increase the utility of adenovirus vectors and also provides a means to efficiently quantify and possibly propagate HSV vectors defective in ICP0. Importantly, the results demonstrate that the activation function of ICP0 may not result from changes in cellular gene expression, but possibly as a direct consequence of an enzymatic function inherent to the protein that may involve its action at ND10 resulting in the preferential activation of viral genomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238865      PMCID: PMC114132          DOI: 10.1128/JVI.75.7.3391-3403.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3.

Authors:  Y Kawaguchi; C Van Sant; B Roizman
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  A herpes simplex virus type 1 mutant containing a deletion within immediate early gene 1 is latency-competent in mice.

Authors:  G B Clements; N D Stow
Journal:  J Gen Virol       Date:  1989-09       Impact factor: 3.891

3.  Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency.

Authors:  D A Leib; D M Coen; C L Bogard; K A Hicks; D R Yager; D M Knipe; K L Tyler; P A Schaffer
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Herpes simplex virus genes involved in latency in vitro.

Authors:  J Russell; N D Stow; E C Stow; C M Preston
Journal:  J Gen Virol       Date:  1987-12       Impact factor: 3.891

5.  Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides.

Authors:  N A DeLuca; P A Schaffer
Journal:  Nucleic Acids Res       Date:  1987-06-11       Impact factor: 16.971

6.  Host species and strain differences affect the ability of an HSV-1 ICP0 deletion mutant to establish latency and spontaneously reactivate in vivo.

Authors:  Y J Gordon; J L McKnight; J M Ostrove; E Romanowski; T Araullo-Cruz
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

7.  Adenovirus vector expressing functional herpes simplex virus ICP0.

Authors:  X X Zhu; C S Young; S Silverstein
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

8.  Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products.

Authors:  X X Zhu; J X Chen; C S Young; S Silverstein
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

9.  Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1.

Authors:  R D Everett
Journal:  J Gen Virol       Date:  1989-05       Impact factor: 3.891

10.  Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system.

Authors:  R A Harris; R D Everett; X X Zhu; S Silverstein; C M Preston
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

View more
  33 in total

1.  Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection.

Authors:  Kasey M Eidson; William E Hobbs; Brian J Manning; Paul Carlson; Neal A DeLuca
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Reversal of heterochromatic silencing of quiescent herpes simplex virus type 1 by ICP0.

Authors:  Michael W Ferenczy; Neal A DeLuca
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

3.  Virus and cell RNAs expressed during Epstein-Barr virus replication.

Authors:  Jing Yuan; Ellen Cahir-McFarland; Bo Zhao; Elliott Kieff
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  Relationship of herpes simplex virus genome configuration to productive and persistent infections.

Authors:  Sara A Jackson; Neal A DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-09       Impact factor: 11.205

5.  A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses.

Authors:  Caroline E Lilley; Mira S Chaurushiya; Chris Boutell; Sebastien Landry; Junghae Suh; Stephanie Panier; Roger D Everett; Grant S Stewart; Daniel Durocher; Matthew D Weitzman
Journal:  EMBO J       Date:  2010-01-14       Impact factor: 11.598

6.  A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome.

Authors:  S K Thomas; C E Lilley; D S Latchman; R S Coffin
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Human cytomegalovirus tegument protein pp71 directs long-term gene expression from quiescent herpes simplex virus genomes.

Authors:  Chris M Preston; Mary Jane Nicholl
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

8.  ICP0 is not required for efficient stress-induced reactivation of herpes simplex virus type 1 from cultured quiescently infected neuronal cells.

Authors:  Craig S Miller; Robert J Danaher; Robert J Jacob
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

9.  Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1.

Authors:  Patrick Lomonte; Joëlle Thomas; Pascale Texier; Cécile Caron; Saadi Khochbin; Alberto L Epstein
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICP0-mediated de-repression.

Authors:  Heather M Coleman; Viv Connor; Zara S C Cheng; Finn Grey; Chris M Preston; Stacey Efstathiou
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.